Clinical Trial Update: GSK2982772 Study in Subjects With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial of GSK2982772 in ulcerative colitis completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GSK2982772 (GSK2982772)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11